Chongqing Tianhai Medical Equipment Sets Up R&D Base In England At Bargain Price
This article was originally published in PharmAsia News
Executive Summary
Chongqing Tianhai Medical Equipment, a Chinese digital medical equipment producer, has officially set up its R&D base in England. It has engaged two top British executives for R&D and sales, at a fraction of their previous salaries. The move represents Chongqing Tianhai's first step toward mergers or acquisitions of European hi-tech medical device companies. The firm sees the global economic crisis as adversely impacting overseas technology enterprises, but providing the opportunity for China's industry to acquire advanced medical device companies and key talent at bargain prices. Other Chinese hi-tech enterprises are also exploring such ventures; in tandem, relevant government departments in China are establishing measures inclined toward funding and support policies. (Click here for more - Chinese Language)
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.